G6PC2 |
2 |
Glucose-6-phosphatase, catalytic, 2 |
Component of an integral membrane system that catalyses glucose-6- phosphate hydrolysis |
Fasting glucose |
Fasting glucose |
GCKR |
2 |
Glucokinase regulator |
Regulatory protein that inhibits glucokinase by forming an inactive complex with the enzyme |
Fasting C-peptide, fasting glucose |
Lipid phenotypes, fasting glucose, 2-h glucose, fasting insulin, Type 2 diabetes |
PCSK1 |
5 |
Proprotein convertase subtilisin/kexin type 1 |
Calcium-dependent serine endoprotease involved in proteolytic activation of several precursor proteins including proinsulin, pro- glucagon-like peptide 1 and pro-opiomelancortin, among others |
Fasting glucose |
Findings not consistent but associated with obesity-related traits, fasting plasma glucose, 2-h plasma glucose, and fasting and post-glucose proinsulin levels |
PPP1R3B |
8 |
Protein phosphatase 1, regulatory subunit 3B |
Facilitates interaction of protein phosphatase 1 with enzymes of glycogen metabolism |
Fasting C-peptide, fasting glucose |
Lipid phenotypes, fasting glucose, C-reactive protein, Type 2 diabetes |
HKDC1 |
10 |
Hexokinase domain containing 1 |
Structure consistent with a hexokinase, but function not yet defined |
2-h glucose |
Nominal association with 2-h glucose in a meta-analysis of over 40 000 individuals |
MTNR1B |
11 |
Melatonin receptor 1B |
G-protein coupled receptor that is expressed on β-cells, binds melatonin and may antagonize insulin release |
Fasting glucose, 1-h glucose |
Fasting glucose, impaired fasting glucose, Type 2 diabetes, altered β-cell function, including decreased insulin release following oral and intravenous glucose |
BACE2 |
21 |
β-site amyloid polypeptide cleaving enzyme 2 |
Not defined |
Fasting C-peptide |
None reported |